Alkermes plc, a biopharmaceutical company, is based in Ireland.
4 reports, 3 independent
Updated Jul 28
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Alkermes plc, a biopharmaceutical company, is based in Ireland.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Alkermes plc is confirmed to be an Ireland-based biopharmaceutical company.1 source
ALK secures exclusive license for EURneffy in UK/EU.1 source
Keep exploring
The entities involved
Related events
Coverage
Newest first; wire copies grouped- Insider MonkeyAlkermes plc (ALKS) Completes Enrollment in Key Narcolepsy Trial, Data Due Q3 2025 We recently compiled a list of the 13 Best Psychedelic Stocks to Invest in Now. Alkermes plc is one of them. Alkerme
- Pharmaceutical TechnologyMHRA approves needle-free adrenaline nasal spray for anaphylaxis The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for EURneffy, an adrenaline (epinephrine) nasal
- PR NewswireAlkermes to Report Second Quarter Financial Results on July 29, 2025 DUBLIN, July 15, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m